Play Live Radio
Next Up:
Available On Air Stations

GSK Will Expand Richmond R&D Facility by 16.7 million Dollars and 150 Workers

GSK Consumer Healthcare Sherwood Avenue Facility
GSK Consumer Healthcare Sherwood Avenue Facility. (Photo: GSK)

The company that makes Advil, Robitussin and Chapstick is planning to expand its Richmond consumer research and development facility and add high-paying jobs in the healthcare field. 

GlaxoSmithKline , GSK, has chosen the Richmond area to make a significant investment in its expanding business.

Lara Fritts:  This expansion will include 150 new employees and over 16 million dollars in new capital investment.

Lara Fritts, President and CEO of the Greater Richmond Partnership

Fritts :  We really think that they chose the greater Richmond region because of our educated workforce, low cost of doing business and outstanding quality of life.

In August, GSK merged with Pfizer to create what they say is the largest, over-the-counter healthcare company in the world, and local officials are pleased that they not only chose to keep the Richmond facility but also to expand it.  Charles Fishburne, VPM News.


Related Stories